BANK OF MONTREAL /CAN/ - FOAMIX PHARMACEUTICALS LTD ownership

FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 66 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of FOAMIX PHARMACEUTICALS LTD
ValueSharesWeighting
Q1 2017$4,000
-50.0%
8360.0%0.00%
Q4 2016$8,0000.0%8360.0%0.00%
Q3 2016$8,000
+60.0%
8360.0%0.00%
Q2 2016$5,0000.0%8360.0%0.00%
Q1 2016$5,0008360.00%
Other shareholders
FOAMIX PHARMACEUTICALS LTD shareholders Q1 2016
NameSharesValueWeighting ↓
DSC Advisors, L.P. 984,734$10,094,0005.25%
SENZAR ASSET MANAGEMENT, LLC 707,449$7,251,0001.24%
MENORA MIVTACHIM HOLDINGS LTD. 1,133,390$11,617,0000.88%
Ghost Tree Capital, LLC 250,000$2,563,0000.83%
Sio Capital Management, LLC 161,286$1,653,0000.82%
SPHERA FUNDS MANAGEMENT LTD. 380,000$3,895,0000.38%
Opaleye Management Inc. 85,000$871,0000.35%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 948,934$9,727,0000.32%
EAM Investors, LLC 261,161$2,677,0000.31%
J. Goldman & Co LP 405,000$4,151,0000.25%
View complete list of FOAMIX PHARMACEUTICALS LTD shareholders